Page 47 - PTP Products
P. 47
Migraine-Cut
www.mimdaroo.com
Application:
After many years of rigorous research and large clinical trials, MIM-Daroo
Pharmaceutical Co. introduced the curative medicine For Migraine
Headaches in 2009.
The first newly developed drug was in the form of inhalation and needed
special processes to be used only at the clinics. The R&D team of MIM-
Daroo was encouraged to develop a new version of migraine curative
medicine.
In 2016, Migraine-Cut , the first spray to Cure Migraine passed all the
requirements and was registered in Food and Drug Administration (FDA) of
Iran and received mass industrial production license.
The clinical trials were performed based on the International Headache
Society (IHS) guidelines on 300 patients.
The curative efficacy of Migraine-Cut has been 81% definite cure (as stated
in the long-term follow-up surveys after the treatment) with nearly 96%
mitigation.
MIMDaroo Pharmaceutical Co.
Field of Activity: Field of Technology:
42 Herbal-based Migraine Headaches Drug
Treatment Drug
